Retraction Retraction dated 2025-07-25
Click to view Retraction: https://doi.org/10.1007/s00280-025-04798-1
-
Authors
Heldrup, Jesper https://orcid.org/0000-0002-6211-1967
Bleyer, Archie https://orcid.org/0000-0001-7738-5146
Ramsey, Laura https://orcid.org/0000-0001-6417-3961
Schaff, Lauren https://orcid.org/0000-0002-4664-670X
Bernhardt, Brooke https://orcid.org/0000-0002-9612-3624
Schwartz, Stefan https://orcid.org/0000-0001-8833-5793
Chatelut, Etienne https://orcid.org/0000-0002-7740-9096
Hwang, Miriam https://orcid.org/0000-0002-0685-4352
Ten, Carolina https://orcid.org/0000-0001-5365-6941
Guscott, Martin https://orcid.org/0000-0001-7842-1559
Howard, Scott https://orcid.org/0000-0003-2244-1686
-
Funding
Funding for this research was provided by:
BTG Specialty Pharmaceuticals
- License Information
-
More Information
Article History
Received: 12 June 2024
Accepted: 1 January 2025
First Online: 13 March 2025
Change Date: 25 July 2025
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1007/s00280-025-04798-1
Declarations
:
: J.H, A.B, L.R, L.S, B.B., S.S, and E.C. received honorarium from BTG Specialty Pharmaceuticals for participation in the roundtable discussions. L.R. received research support and consulting fees from BTG Specialty Pharmaceuticals. L.S. and B.B. received research support from and was on the advisory board for BTG Specialty Pharmaceuticals. S.S. received research support from Protherics Medicine Development, Ltd; received honoraria from SERB Pharmaceuticals, Akademie für Infektionsmedizin, AMGEN, AvirPharma, CSi Hamburg, Labor28, Pfizer; received travel grants from and is/was an advisory board member of AMGEN, Gilead, Pfizer, SERB Pharmaceuticals. E.C. received consulting fees from SERB Pharmaceuticals; serves as co-Editor-in-Chief for Cancer Chemotherapy and Pharmacology. S.H. received research support and speaker honorarium from BTG Specialty Pharmaceuticals. M.H, C.T., and M.G declare no financial interests.
: Not applicable.
: Not applicable.
